Tagged: ADXS Toggle Comment Threads | Keyboard Shortcuts




ADXS Stock News | ADXS Financials On Finviz | ADXS Stock Search | ADXS Stock Chart is Delayed

  • investorsocialnetwork

    Zitrof 8:35 pm on July 13, 2018 Permalink | Reply
    Tags: ADXS   

    Advaxis, Inc. #ADXS up on news the FDA lifted the clinical hold on its Phase 1/2 trial of axalimogene filolisbac (AXAL) in combination with durvalumab for the treatment of patients with advanced, recurrent or refractory cervical cancer and HPV-associated head and neck cancer.

     
  • investorsocialnetwork

    Zitrof 8:09 am on July 11, 2018 Permalink | Reply
    Tags: ADXS   

    Advaxis, Inc. #ADXS announced that it intends to withdraw its Marketing Authorization Application, MAA, in the European Union for axalimogene filolisbac to treat metastatic cervical cancer in patients who progress beyond first-line therapy. The action follows feedback from the European Medicines Agency, EMA, that additional data to support a conditional approval are required.

     
c
compose new post
j
next post/next comment
k
previous post/previous comment
r
reply
e
edit
o
show/hide comments
t
go to top
l
go to login
h
show/hide help
shift + esc
cancel